ZA200801645B - Hydroxy substituted 1H-imidazopyridines and methods - Google Patents
Hydroxy substituted 1H-imidazopyridines and methodsInfo
- Publication number
- ZA200801645B ZA200801645B ZA200801645A ZA200801645A ZA200801645B ZA 200801645 B ZA200801645 B ZA 200801645B ZA 200801645 A ZA200801645 A ZA 200801645A ZA 200801645 A ZA200801645 A ZA 200801645A ZA 200801645 B ZA200801645 B ZA 200801645B
- Authority
- ZA
- South Africa
- Prior art keywords
- imidazopyridines
- methods
- hydroxy substituted
- hydroxy
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71370405P | 2005-09-02 | 2005-09-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200801645B true ZA200801645B (en) | 2010-08-25 |
Family
ID=37561219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200801645A ZA200801645B (en) | 2005-09-02 | 2008-02-19 | Hydroxy substituted 1H-imidazopyridines and methods |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20100152230A1 (ru) |
| EP (1) | EP1924581A1 (ru) |
| JP (1) | JP4584335B2 (ru) |
| KR (1) | KR20080031496A (ru) |
| CN (1) | CN101253173A (ru) |
| AU (1) | AU2006287157A1 (ru) |
| BR (1) | BRPI0615250A2 (ru) |
| CA (1) | CA2620933A1 (ru) |
| CR (1) | CR9781A (ru) |
| EA (1) | EA200800396A1 (ru) |
| EC (1) | ECSP088225A (ru) |
| IL (1) | IL189262A0 (ru) |
| MA (1) | MA29759B1 (ru) |
| MX (1) | MX2008002414A (ru) |
| NO (1) | NO20081393L (ru) |
| RS (1) | RS20080128A (ru) |
| SV (1) | SV2009002832A (ru) |
| TN (1) | TNSN08099A1 (ru) |
| WO (1) | WO2007028129A1 (ru) |
| ZA (1) | ZA200801645B (ru) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
| WO2005018556A2 (en) | 2003-08-12 | 2005-03-03 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo-containing compounds |
| ES2406730T3 (es) | 2003-08-27 | 2013-06-07 | 3M Innovative Properties Company | Imidazoquinolinas sustituidas con ariloxi y arilalquilenoxi |
| AU2004270201A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for CD5+ B cell lymphoma |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| CA2540598C (en) | 2003-10-03 | 2013-09-24 | 3M Innovative Properties Company | Pyrazolopyridines and analogs thereof |
| CA2540541C (en) | 2003-10-03 | 2012-03-27 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| WO2005048945A2 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| EP1685129A4 (en) | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | OXIMSUBSTITUTED IMIDAZORING CONNECTIONS |
| JP4891088B2 (ja) | 2003-11-25 | 2012-03-07 | スリーエム イノベイティブ プロパティズ カンパニー | 置換されたイミダゾ環系および方法 |
| JP2007517035A (ja) | 2003-12-29 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン |
| CA2551399A1 (en) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| CA2559863A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| AU2005326708C1 (en) | 2004-12-30 | 2012-08-30 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| AU2005322898B2 (en) | 2004-12-30 | 2011-11-24 | 3M Innovative Properties Company | Chiral fused (1,2)imidazo(4,5-c) ring compounds |
| CA2597092A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
| AU2006338521A1 (en) | 2005-02-09 | 2007-10-11 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods |
| US20080318998A1 (en) | 2005-02-09 | 2008-12-25 | Coley Pharmaceutical Group, Inc. | Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines |
| WO2006086634A2 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| US8658666B2 (en) | 2005-02-11 | 2014-02-25 | 3M Innovative Properties Company | Substituted imidazoquinolines and imidazonaphthyridines |
| JP2008538203A (ja) | 2005-02-23 | 2008-10-16 | コーリー ファーマシューティカル グループ，インコーポレイテッド | インターフェロンの生合成を優先的に誘導する方法 |
| EP1851224A2 (en) | 2005-02-23 | 2007-11-07 | 3M Innovative Properties Company | Hydroxyalkyl substituted imidazoquinolines |
| AU2006216798A1 (en) | 2005-02-23 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Hydroxyalkyl substituted imidazoquinoline compounds and methods |
| CA2602590A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| EP1869043A2 (en) | 2005-04-01 | 2007-12-26 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| JP2009507856A (ja) | 2005-09-09 | 2009-02-26 | コーリー ファーマシューティカル グループ，インコーポレイテッド | Ｎ−｛２−［４−アミノ−２−（エトキシメチル）−１Ｈ−イミダゾ［４，５−ｃ］キノリン−１−イル］−１，１−ジメチルエチル｝メタンスルホンアミドのアミドおよびカルバマート誘導体ならびに方法 |
| ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| JP5247458B2 (ja) | 2005-11-04 | 2013-07-24 | スリーエム・イノベイティブ・プロパティーズ・カンパニー | ヒドロキシ及びアルコキシ置換１ｈ−イミダゾキノリン及び方法 |
| MX2008010611A (es) | 2006-02-17 | 2008-11-12 | Pfizer Ltd | Derivados de 3-desazapurina como moduladores de receptores similares a toll. |
| US8951528B2 (en) | 2006-02-22 | 2015-02-10 | 3M Innovative Properties Company | Immune response modifier conjugates |
| WO2007106854A2 (en) | 2006-03-15 | 2007-09-20 | Coley Pharmaceutical Group, Inc. | Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods |
| WO2008008432A2 (en) | 2006-07-12 | 2008-01-17 | Coley Pharmaceutical Group, Inc. | Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| WO2008030511A2 (en) | 2006-09-06 | 2008-03-13 | Coley Pharmaceuticial Group, Inc. | Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
| US20080149123A1 (en) | 2006-12-22 | 2008-06-26 | Mckay William D | Particulate material dispensing hairbrush with combination bristles |
| DE602008003764D1 (de) | 2007-02-19 | 2011-01-13 | Glaxosmithkline Llc | Purinderivate als immunmodulatoren |
| EP1997805A1 (en) * | 2007-06-01 | 2008-12-03 | Commissariat à l'Energie Atomique | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
| CA2707030A1 (en) * | 2007-08-03 | 2009-02-12 | Pfizer Limited | Imidazopyridinones |
| LT2320905T (lt) | 2008-08-11 | 2017-09-11 | Glaxosmithkline Llc | Naujieji adenino dariniai |
| UA103195C2 (ru) | 2008-08-11 | 2013-09-25 | Глаксосмитклайн Ллк | Производные пурина для применения в лечении аллергий, воспалительных и инфекционных заболеваний |
| US8802684B2 (en) | 2008-08-11 | 2014-08-12 | Glaxosmithkline Llc | Adenine derivatives |
| US8575181B2 (en) | 2008-08-11 | 2013-11-05 | Glaxosmithkline Llc | Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| EA021377B9 (ru) | 2008-12-09 | 2015-09-30 | Джилид Сайэнс, Инк. | Модуляторы толл-подобных рецепторов |
| CA2772071A1 (en) | 2009-08-28 | 2011-03-03 | Array Biopharma Inc. | Raf inhibitor compounds and methods of use thereof |
| SI2491035T1 (sl) * | 2009-10-22 | 2017-10-30 | Gilead Sciences, Inc. | Derivati purina ali deazapurina uporabni za zdravljenje (med drugimi) virusnih okužb |
| US8575340B2 (en) | 2010-02-10 | 2013-11-05 | Glaxosmithkline Llc | Purine derivatives and their pharmaceutical uses |
| HUE033901T2 (en) | 2010-08-17 | 2018-01-29 | 3M Innovative Properties Co | Formulations and formulations for lipidized immune response modifying compounds and related processes |
| JP6415979B2 (ja) | 2011-06-03 | 2018-10-31 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドラジノ１ｈ−イミダゾキノリン−４−アミン及びこれから調製された複合体 |
| CA2838158C (en) | 2011-06-03 | 2019-07-16 | 3M Innovative Properties Company | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| RU2631482C2 (ru) | 2011-07-22 | 2017-09-22 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Композиция |
| CN103450198B (zh) * | 2012-05-29 | 2015-07-08 | 首都医科大学 | 咪唑并吡啶并咪唑-3-取代乙酸苄酯、其合成、抗肿瘤活性及应用 |
| WO2014031815A1 (en) | 2012-08-24 | 2014-02-27 | Glaxosmithkline Llc | Pyrazolopyrimidine compounds |
| KR20150085081A (ko) | 2012-11-20 | 2015-07-22 | 글락소스미스클라인 엘엘씨 | 신규 화합물 |
| WO2014081645A1 (en) | 2012-11-20 | 2014-05-30 | Glaxosmithkline Llc | Novel compounds |
| EP2922550B1 (en) | 2012-11-20 | 2017-04-19 | Glaxosmithkline LLC | Novel compounds |
| UY36298A (es) | 2014-09-16 | 2016-04-29 | Gilead Science Inc | Formas sólidas de un modulador del receptor tipo toll |
| JP7197244B2 (ja) | 2017-12-20 | 2022-12-27 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答調節剤として使用するための分岐鎖連結基を有するアミド置換イミダゾ［４，５－ｃ］キノリン化合物 |
| WO2019209811A1 (en) | 2018-04-24 | 2019-10-31 | Bristol-Myers Squibb Company | Macrocyclic toll-like receptor 7 (tlr7) agonists |
| US11554120B2 (en) | 2018-08-03 | 2023-01-17 | Bristol-Myers Squibb Company | 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor |
| US20230144824A1 (en) | 2020-01-27 | 2023-05-11 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
| KR20220132591A (ko) | 2020-01-27 | 2022-09-30 | 브리스톨-마이어스 스큅 컴퍼니 | 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물 |
| EP4097103A1 (en) | 2020-01-27 | 2022-12-07 | Bristol-Myers Squibb Company | 1h-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (tlr7) agonists |
| CN115210236A (zh) | 2020-01-27 | 2022-10-18 | 百时美施贵宝公司 | 作为Toll样受体7(TLR7)激动剂的1H-吡唑并[4,3-d]嘧啶化合物 |
| EP4097105A1 (en) | 2020-01-27 | 2022-12-07 | Bristol-Myers Squibb Company | 1h-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (tlr7) agonists |
| KR20220132594A (ko) | 2020-01-27 | 2022-09-30 | 브리스톨-마이어스 스큅 컴퍼니 | 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물 |
| JP2023512206A (ja) | 2020-01-27 | 2023-03-24 | ブリストル－マイヤーズ スクイブ カンパニー | トール様受容体７（ＴＬＲ７）アゴニストとしての１Ｈ－ピラゾロ［４，３－ｄ］ピリミジン化合物 |
| EP4097107A1 (en) | 2020-01-27 | 2022-12-07 | Bristol-Myers Squibb Company | C3-substituted 1h-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (tlr7) agonists |
| KR20220132601A (ko) | 2020-01-27 | 2022-09-30 | 브리스톨-마이어스 스큅 컴퍼니 | 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물 |
| CN117466808B (zh) * | 2023-12-27 | 2024-03-12 | 烟台新药创制山东省实验室 | 一种6-烷基-2,4-二羟基吡啶类衍生物的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09500128A (ja) * | 1993-07-15 | 1997-01-07 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | イミダゾ〔４，５−ｃ〕ピリジン−４−アミン |
| WO1998001448A1 (fr) * | 1996-07-03 | 1998-01-15 | Japan Energy Corporation | Nouveaux derives de purine |
| KR100892614B1 (ko) * | 2001-04-17 | 2009-04-09 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규 아데닌 유도체 |
| EP1389618B1 (en) * | 2001-04-27 | 2011-06-15 | Eisai R&D Management Co., Ltd. | Pyrazolo 1,5-a pyridines and medicines containing the same |
| AU2003237386A1 (en) * | 2002-06-07 | 2003-12-22 | 3M Innovative Properties Company | Ether substituted imidazopyridines |
| TWI325865B (en) * | 2003-02-27 | 2010-06-11 | Palau Pharma Sa | Pyrazolopyridine derivatives |
| US7517887B2 (en) * | 2003-04-09 | 2009-04-14 | General Atomics | Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| JP2005089334A (ja) * | 2003-09-12 | 2005-04-07 | Sumitomo Pharmaceut Co Ltd | ８−ヒドロキシアデニン化合物 |
| CN1997642B (zh) * | 2003-09-22 | 2012-06-13 | 詹森药业有限公司 | 7-氨基亚烷基-杂环喹诺酮类和萘啶酮类 |
| FR2860514A1 (fr) * | 2003-10-03 | 2005-04-08 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
| EP1685129A4 (en) * | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | OXIMSUBSTITUTED IMIDAZORING CONNECTIONS |
| JP4891088B2 (ja) * | 2003-11-25 | 2012-03-07 | スリーエム イノベイティブ プロパティズ カンパニー | 置換されたイミダゾ環系および方法 |
| TW200616604A (en) * | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| MX2008010611A (es) * | 2006-02-17 | 2008-11-12 | Pfizer Ltd | Derivados de 3-desazapurina como moduladores de receptores similares a toll. |
-
2006
- 2006-09-01 CN CNA2006800319190A patent/CN101253173A/zh active Pending
- 2006-09-01 JP JP2008529359A patent/JP4584335B2/ja not_active Expired - Fee Related
- 2006-09-01 RS RSP-2008/0128A patent/RS20080128A/sr unknown
- 2006-09-01 MX MX2008002414A patent/MX2008002414A/es unknown
- 2006-09-01 WO PCT/US2006/034427 patent/WO2007028129A1/en active Application Filing
- 2006-09-01 US US12/065,490 patent/US20100152230A1/en not_active Abandoned
- 2006-09-01 KR KR1020087005146A patent/KR20080031496A/ko not_active Application Discontinuation
- 2006-09-01 AU AU2006287157A patent/AU2006287157A1/en not_active Abandoned
- 2006-09-01 BR BRPI0615250-3A patent/BRPI0615250A2/pt not_active IP Right Cessation
- 2006-09-01 CA CA002620933A patent/CA2620933A1/en not_active Abandoned
- 2006-09-01 EA EA200800396A patent/EA200800396A1/ru unknown
- 2006-09-01 EP EP06802901A patent/EP1924581A1/en not_active Withdrawn
-
2008
- 2008-02-04 IL IL189262A patent/IL189262A0/en unknown
- 2008-02-19 ZA ZA200801645A patent/ZA200801645B/xx unknown
- 2008-02-26 EC EC2008008225A patent/ECSP088225A/es unknown
- 2008-02-29 TN TNP2008000099A patent/TNSN08099A1/fr unknown
- 2008-02-29 MA MA30694A patent/MA29759B1/fr unknown
- 2008-02-29 SV SV2008002832A patent/SV2009002832A/es not_active Application Discontinuation
- 2008-02-29 CR CR9781A patent/CR9781A/es not_active Application Discontinuation
- 2008-03-17 NO NO20081393A patent/NO20081393L/no not_active Application Discontinuation
-
2011
- 2011-10-20 US US13/277,619 patent/US20120035209A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN08099A1 (fr) | 2009-07-14 |
| EP1924581A1 (en) | 2008-05-28 |
| IL189262A0 (en) | 2008-06-05 |
| CR9781A (es) | 2008-03-26 |
| RS20080128A (en) | 2009-05-06 |
| CN101253173A (zh) | 2008-08-27 |
| KR20080031496A (ko) | 2008-04-08 |
| JP4584335B2 (ja) | 2010-11-17 |
| MA29759B1 (fr) | 2008-09-01 |
| WO2007028129A1 (en) | 2007-03-08 |
| EA200800396A1 (ru) | 2008-08-29 |
| SV2009002832A (es) | 2009-02-19 |
| ECSP088225A (es) | 2008-03-26 |
| AU2006287157A1 (en) | 2007-03-08 |
| BRPI0615250A2 (pt) | 2011-05-10 |
| JP2009507036A (ja) | 2009-02-19 |
| US20100152230A1 (en) | 2010-06-17 |
| MX2008002414A (es) | 2008-03-27 |
| NO20081393L (no) | 2008-05-28 |
| US20120035209A1 (en) | 2012-02-09 |
| CA2620933A1 (en) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200801645B (en) | Hydroxy substituted 1H-imidazopyridines and methods | |
| IL191060A0 (en) | Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods | |
| PL1951030T3 (pl) | Udoskonalone sposoby i środki do wytwarzania hialuronianu | |
| EP1846419A4 (en) | ALKYLOXYSUBSTITUTED THIAZOLOCHINOLINE AND THIAZOLONAPHTHYRIDINE | |
| IL185280A0 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
| EP1987397A4 (en) | APPARATUS AND METHODS OF WRITING | |
| GB0502298D0 (en) | Well assembly and method | |
| PL1729273T3 (pl) | Tabliczka informacyjna | |
| GB0525957D0 (en) | Methods | |
| IL191609A0 (en) | Nanoparticle and methods therefor | |
| GB0518877D0 (en) | Markers and methods | |
| GB0715741D0 (en) | Methods | |
| GB0518425D0 (en) | Methods | |
| GB0516204D0 (en) | Methods | |
| EP1938123A4 (en) | SHIELD STRUCTURE AND METHOD | |
| GB0526212D0 (en) | Methods | |
| GB0502858D0 (en) | Device and method | |
| GB0514661D0 (en) | Methods | |
| GB0522696D0 (en) | Balustrading kit and method | |
| GB0518875D0 (en) | Methods and means | |
| GB0502843D0 (en) | Jig-was and jig-will | |
| GB2430450B (en) | Orthoester-based surfactants and associated methods | |
| PT1951030E (pt) | Métodos e meios melhorados para produzir hialuronano | |
| GB0520311D0 (en) | Methods | |
| GB0506709D0 (en) | Methods |